Alphatec Holdings Launches IdentiTI PO Interbody Implant System

Medical Device Investing

The launch comes after successful alpha evaluations that started in January and makes the fifth of six systems to be launched in 2019.

Alphatec Holdings (NASDAQ:ATEC) has announced it has commercially launched its IdentiTI TLIF Posterior Oblique Titanium Interbody Implant System.

As quoted in the press release:

The launch of IdentiTi (TLIF) PO follows successful alpha evaluations that began in January 2019 and marks the fifth of six IdentiTi Implant Systems to be launched this year by ATEC’s Organic Innovation Machine™.
“We continue to execute exceptionally well in our pursuit of increased market share through clinical distinction,” said Pat Miles, Chairman and Chief Executive Officer. “ATEC’s line of IdentiTi Implant Systems brings modernized technology to our portfolio that improves outcomes and elevates the sophistication of spine fusion. The latest addition of IdentiTi (TLIF) PO provides that same sophistication to those preferring to place oblique implants during a TLIF approach. It is incredibly exciting to see the investments we’ve made into innovation reach fruition and begin to accelerate growth organically.”
IdentiTi TLIF Posterior Oblique Porous Titanium Interbody Implant System
With a self-distracting bulleted nose, smooth medial-lateral surfaces, and rounded edges, IdentiTi PO has been thoughtfully engineered to improve implant insertion while protecting soft tissue and nerve roots. IdentiTi PO implants are also uniquely designed with anti-migration teeth and lordosis in the oblique plane to optimize surgical outcomes.

Click here to read the full press release.

alphatec holdings nasdaq:atec Medical Device Investing